scispace - formally typeset
E

Erland Arning

Researcher at Baylor University

Publications -  38
Citations -  893

Erland Arning is an academic researcher from Baylor University. The author has contributed to research in topics: Homocysteine & Hyperhomocysteinemia. The author has an hindex of 17, co-authored 38 publications receiving 777 citations. Previous affiliations of Erland Arning include Veterans Health Administration & Roy J. and Lucille A. Carver College of Medicine.

Papers
More filters
Journal ArticleDOI

Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia

TL;DR: It is concluded that hyperhomocysteinemia enhances susceptibility to arterial thrombosis through a mechanism that is not caused by loss of endothelium-derived nitric oxide but may involve oxidative stress and impairment of the protein C anticoagulant pathway.
Journal ArticleDOI

Hyperhomocysteinemia Potentiates Hyperglycemia-induced Inflammatory Monocyte Differentiation and Atherosclerosis

TL;DR: It is demonstrated that HHcy and HG accelerated atherosclerosis and increased lesion monocytes and macrophages and further increased inflammatory MC and MØ levels in peripheral tissues and HHcy-lowering reversed circulating mononuclear cells, MC, and inflammatoryMC and MC-derived M Ø levels.
Journal ArticleDOI

Cerebral Vascular Dysfunction in Methionine Synthase–Deficient Mice

TL;DR: It is demonstrated that defective homocysteine remethylation caused by deficiency of either MS or folate produces oxidative stress and endothelial dysfunction in the cerebral microcirculation of mice.
Journal ArticleDOI

Effects of exercise on emerging and traditional cardiovascular risk factors.

TL;DR: Although frequent bouts of higher intensity exercise were particularly effective in reducing fasting insulin and improving fitness, they resulted in slightly increased homocysteine levels.
Journal ArticleDOI

Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.

TL;DR: It is found that vitamin B12-dependent methionine metabolism is dysregulated in the MS brain and concentrations of the methyl donor betaine are decreased in MS cortex and are correlated with reduced levels of the histone H3 methyl mark H3K4me3 in neurons.